ALLISON KLINK: Open Payments
NPI 1386375327 · MAUMEE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 22 payments from 10 companies in 2025. Trend: 2023 $604 · 2024 $551 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Dexcom, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Exact Sciences Corporation | 1 | $16 |
Products named: AIRSUPRA, REXULTI, Dexcom G6 Transmitter, TRELEGY ELLIPTA, XIFAXAN, MOUNJARO, FARXIGA, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
